This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment
of Lyme disease was developed by a multidisciplinary panel representing the Infectious …

Lyme borreliosis affects the nervous system in three principal ways—mononuclear cell
meningitis, cranial neuropathies and radiculoneuropathies—the last a broad term …

Aims Brain disease, in its many forms, has recently demonstrated a great socio-economic
impact and represents one of the hardest challenges of present research. Although each …

CXC-motif chemokine ligand 13 (CXCL13) in cerebrospinal fluid (CSF) is increasingly used
in clinical routines, although its diagnostic specificity and divergent cut-off values have been …

Objectives Facial palsy is the most common manifestation of Lyme neuroborreliosis (LNB) in
the United States. This study aimed to describe features of patients with early LNB …

CXCL13 in cerebrospinal fluid has gradually become an established biomarker for Lyme
neuroborreliosis (LNB), however the diagnostic performance of CXCL13 may be improved …

Affections of the central nervous system (CNS) rarely occur in Lyme neuroborreliosis (LNB).
CNS manifestations can have residual neurological symptoms despite antibiotic treatment …

Background and purpose The characteristics and long‐term outcome of Lyme
neuroborreliosis (LNB) according to diagnostic certainty (definite vs. possible) are …

Lyme neuroborreliosis (LNB) in Europe may manifest with painful meningoradiculoneuritis
(also known as Bannwarth syndrome) or lymphocytic meningitis with or without cranial …

Diagnostic tools to differentiate between community-acquired bacterial and viral meningitis
are essential to target the potentially lifesaving antibiotic treatment to those at greatest risk …